The device was not returned for evaluation.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.The reported patient effect of angina is listed in the xience xpedition everolimus eluting coronary stent systems instructions for use as a known patient effect of coronary procedures.A conclusive cause for the reported patient effects, and the relationship to the product, if any, cannot be determined.There is no indication of a product quality issue with respect to manufacture, design or labeling.
|
It was reported that on (b)(6) 2014, the patient was hospitalized for paroxysmal chest tightness due to 99% stenosis in the middle and distal left anterior descending artery.Coronary angiography was performed and a 3.0x33mm, 3.5x38mm, and 3.5x28mm xience xpedition stents were successfully implanted at the lesion.The patient was discharged on (b)(6) 2014.In (b)(6) 2018, the patient was rehospitalized due to chest tightness and shortness of breath.Routine examinations such as routine blood and electrocardiogram were performed.No coronary angiography or computed tomography examination was performed, and no obvious abnormalities were found.The patient had chest tightness and shortness of breath occasionally during the night.No treatment was provided.The relationship between the event and the device is not known.There was no adverse patient sequela and no clinically significant delay.No additional information was provided.
|